228 related articles for article (PubMed ID: 28302417)
21. MUC1-C intersects chronic inflammation with epigenetic reprogramming by regulating the set1a compass complex in cancer progression.
Bhattacharya A; Fushimi A; Wang K; Yamashita N; Morimoto Y; Ishikawa S; Daimon T; Liu T; Liu S; Long MD; Kufe D
Commun Biol; 2023 Oct; 6(1):1030. PubMed ID: 37821650
[TBL] [Abstract][Full Text] [Related]
22. MUC1 in hematological malignancies.
Stroopinsky D; Kufe D; Avigan D
Leuk Lymphoma; 2016 Nov; 57(11):2489-98. PubMed ID: 27347699
[TBL] [Abstract][Full Text] [Related]
23. MUC1-C induces DNA methyltransferase 1 and represses tumor suppressor genes in acute myeloid leukemia.
Tagde A; Rajabi H; Stroopinsky D; Gali R; Alam M; Bouillez A; Kharbanda S; Stone R; Avigan D; Kufe D
Oncotarget; 2016 Jun; 7(26):38974-38987. PubMed ID: 27259275
[TBL] [Abstract][Full Text] [Related]
24. Evolution of the human MUC1 oncoprotein.
Duraisamy S; Kufe T; Ramasamy S; Kufe D
Int J Oncol; 2007 Sep; 31(3):671-7. PubMed ID: 17671696
[TBL] [Abstract][Full Text] [Related]
25. Analysis of the TGFβ-induced program in primary airway epithelial cells shows essential role of NF-κB/RelA signaling network in type II epithelial mesenchymal transition.
Tian B; Li X; Kalita M; Widen SG; Yang J; Bhavnani SK; Dang B; Kudlicki A; Sinha M; Kong F; Wood TG; Luxon BA; Brasier AR
BMC Genomics; 2015 Jul; 16(1):529. PubMed ID: 26187636
[TBL] [Abstract][Full Text] [Related]
26. Epigenetic regulation of epithelial-mesenchymal transition.
Sun L; Fang J
Cell Mol Life Sci; 2016 Dec; 73(23):4493-4515. PubMed ID: 27392607
[TBL] [Abstract][Full Text] [Related]
27. MUC1-C activates the TAK1 inflammatory pathway in colon cancer.
Takahashi H; Jin C; Rajabi H; Pitroda S; Alam M; Ahmad R; Raina D; Hasegawa M; Suzuki Y; Tagde A; Bronson RT; Weichselbaum R; Kufe D
Oncogene; 2015 Oct; 34(40):5187-97. PubMed ID: 25659581
[TBL] [Abstract][Full Text] [Related]
28. Biphasic Alterations in Expression and Subcellular Localization of MUC1 in Pancreatic Ductal Carcinogenesis in Syrian Hamsters.
Kitahashi T; Takahashi M; Imai T
Pancreas; 2015 Jan; 44(1):76-86. PubMed ID: 25036908
[TBL] [Abstract][Full Text] [Related]
29. Targeting MUC1-C suppresses polycomb repressive complex 1 in multiple myeloma.
Tagde A; Markert T; Rajabi H; Hiraki M; Alam M; Bouillez A; Avigan D; Anderson K; Kufe D
Oncotarget; 2017 Sep; 8(41):69237-69249. PubMed ID: 29050200
[TBL] [Abstract][Full Text] [Related]
30. MUC1-C represses the RASSF1A tumor suppressor in human carcinoma cells.
Rajabi H; Hata T; Li W; Long MD; Hu Q; Liu S; Raina D; Kui L; Yasumizu Y; Hong D; Samur M; Kufe D
Oncogene; 2019 Nov; 38(47):7266-7277. PubMed ID: 31435022
[TBL] [Abstract][Full Text] [Related]
31. Epigenetics of epithelial-to-mesenchymal transition in pancreatic carcinoma.
Träger MM; Dhayat SA
Int J Cancer; 2017 Jul; 141(1):24-32. PubMed ID: 28133736
[TBL] [Abstract][Full Text] [Related]
32. MUC1-C oncoprotein as a target in breast cancer: activation of signaling pathways and therapeutic approaches.
Kufe DW
Oncogene; 2013 Feb; 32(9):1073-81. PubMed ID: 22580612
[TBL] [Abstract][Full Text] [Related]
33. The Role of Histone Variants in the Epithelial-To-Mesenchymal Transition.
Lone IN; Sengez B; Hamiche A; Dimitrov S; Alotaibi H
Cells; 2020 Nov; 9(11):. PubMed ID: 33213091
[TBL] [Abstract][Full Text] [Related]
34. MUC1 inhibition leads to decrease in PD-L1 levels via upregulation of miRNAs.
Pyzer AR; Stroopinsky D; Rosenblatt J; Anastasiadou E; Rajabi H; Washington A; Tagde A; Chu JH; Coll M; Jiao AL; Tsai LT; Tenen DE; Cole L; Palmer K; Ephraim A; Leaf RK; Nahas M; Apel A; Bar-Natan M; Jain S; McMasters M; Mendez L; Arnason J; Raby BA; Slack F; Kufe D; Avigan D
Leukemia; 2017 Dec; 31(12):2780-2790. PubMed ID: 28555079
[TBL] [Abstract][Full Text] [Related]
35. Emergence of
Kufe DW
Cancers (Basel); 2022 Sep; 14(19):. PubMed ID: 36230728
[TBL] [Abstract][Full Text] [Related]
36. MUC1 upregulation promotes immune resistance in tumor cells undergoing brachyury-mediated epithelial-mesenchymal transition.
David JM; Hamilton DH; Palena C
Oncoimmunology; 2016 Apr; 5(4):e1117738. PubMed ID: 27141403
[TBL] [Abstract][Full Text] [Related]
37. Epigenetic control of epithelial-to-mesenchymal transition and cancer metastasis.
Wang Y; Shang Y
Exp Cell Res; 2013 Jan; 319(2):160-9. PubMed ID: 22935683
[TBL] [Abstract][Full Text] [Related]
38. Regulation of epithelial-mesenchymal transition through epigenetic and post-translational modifications.
Serrano-Gomez SJ; Maziveyi M; Alahari SK
Mol Cancer; 2016 Feb; 15():18. PubMed ID: 26905733
[TBL] [Abstract][Full Text] [Related]
39. Epigenetic silencing of IRF1 dysregulates type III interferon responses to respiratory virus infection in epithelial to mesenchymal transition.
Yang J; Tian B; Sun H; Garofalo RP; Brasier AR
Nat Microbiol; 2017 Jun; 2():17086. PubMed ID: 28581456
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic regulation of epithelial to mesenchymal transition by the Lysine-specific demethylase LSD1/KDM1A.
Ambrosio S; Saccà CD; Majello B
Biochim Biophys Acta Gene Regul Mech; 2017 Sep; 1860(9):905-910. PubMed ID: 28720390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
